CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 1,233 enrolled
Drug / intervention
CenteringPregnancy Plus (CP+) +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00628771
NCT00628771Phase 4Completed

Integrating Prenatal Care to Reduce HIV/STDs Among Teens: A Translational Study

Yale University·interventional·Posted Mar 5, 2008·Updated Apr 3, 2020

In Brief

A Phase 4 clinical trial evaluating CenteringPregnancy Plus (CP+) and Usual care for Pregnancy and 2 related conditions. Completed, enrolled 1,233 participants across 3 sites.

Detailed Summary

This study will evaluate the effectiveness of CenteringPregnancy Plus, a group prenatal care treatment program with an HIV/sexually transmitted disease prevention component, in reducing health risk behaviors in pregnant teenagers seeking services at Community Health Centers in the New York metropolitan area.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 5, 2008
Enrollment StartJun 1, 2008
Primary CompletionSep 1, 2012
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 18.3 years ago

Interventions

CenteringPregnancy Plus (CP+)behavioral

The CenteringPregnancy model of group prenatal care involves skill-building in the areas of efficacy, risk assessment, negotiation, and prevention. CP+ integrates HIV prevention into prenatal care, builds on motivations for healthy pregnancy, and creates a sustainable model via reimbursement mechanisms for prenatal care. There will be ten 2-hour prenatal group sessions.

Usual carebehavioral

Usual care includes standard individual prenatal care and no prenatal group sessions.